Hepatology: researching cirrhosis, HBV and intestinal microflora
A report on the impact of COVID-19 on patients with decompensated cirrhosis, along with an overview of HBV and the role of intestinal microflora in alcohol-related liver disease.
This story is Premium Content and is only available to registered users. Please log in to view the full text. If you don't already have an account, please register with us completely free of charge.